Development of an algorithm to identify serious opioid toxicity in children

被引:18
作者
Chung C.P. [1 ]
Callahan S.T. [3 ]
Cooper W.O. [2 ,3 ]
Murray K.T. [1 ]
Hall K. [2 ]
Dudley J.A. [2 ]
Stein C.M. [1 ]
Ray W.A. [2 ]
机构
[1] Division of Rheumatology, Department of Medicine, Vanderbilt University School of Medicine, 1161 21st Ave. S., Nashville, 37232, TN
[2] Department of Health Policy, Vanderbilt University School of Medicine, Nashville, 37232, TN
[3] Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, 37232, TN
关键词
Algorithm; Children; Opioid; Poisoning; Toxicity; Validation;
D O I
10.1186/s13104-015-1185-x
中图分类号
学科分类号
摘要
Background: The use of opioids is increasing in children; therefore, opioid toxicity could be a public health problem in this vulnerable population. However, we are not aware of a published algorithm to identify cases of opioid toxicity in children using administrative databases. We sought to develop an algorithm to identify them. After review of literature and de-identified computer profiles, a broad set of ICD-9 CM codes consistent with serious opioid toxicity was selected. Based on these codes, we identified 195 potential cases of opioid toxicity in children enrolled in Tennessee Medicaid. Medical records were independently reviewed by two physicians; episodes considered equivocal were reviewed by an adjudication committee. Cases were adjudicated as Group 1 (definite/probable), Group 2 (possible), or Group 3 (excluded). Results: Of the 195 potential cases, 168 (86.2%) had complete records for review and 85 were confirmed cases. The overall positive predictive value (PPV) for all codes was 50.6%. The PPV for codes indicating: unintentional opioid overdose (25/31) was 80.7%; intentional opioid overdose (15/30) was 50.0%, adverse events (33/58) was 56.9%, the presence of signs or symptoms compatible with opioid toxicity (12/47) was 25.5%, and no cases were confirmed in records from the two deaths. Of the confirmed cases, 65.8% were related to therapeutic opioid use. Conclusion: For studies utilizing administrative claims to quantify incidence of opioid toxicity in children, our findings suggest that use of a broad set of screening codes coupled with medical record review is important to increase the completeness of case ascertainment. © 2015 Chung et al.
引用
收藏
相关论文
共 18 条
[1]  
Okie S., A flood of opioids, a rising tide of deaths, N Engl J Med, 363, 21, pp. 1981-1985, (2010)
[2]  
Kuehn B.M., Opioid prescriptions soar: Increase in legitimate use as well as abuse, JAMA, 297, 3, pp. 249-251, (2007)
[3]  
Dunn K.M., Saunders K.W., Rutter C.M., Banta-Green C.J., Merrill J.O., Sullivan M.D., Et al., Opioid prescriptions for chronic pain and overdose, Ann Intern Med, 152, 2, pp. 85-92, (2010)
[4]  
Centers for Disease Control and Prevention, Vital signs: Overdoses of prescription opioid pain relievers - United States, 1999-2008, MMWR Morb Mortal Wkly Rep, 60, pp. 1487-1492, (2011)
[5]  
Takata G.S., Mason W., Taketomo C., Logsdon T., Sharek P.J., Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals, Pediatrics, 121, 4, pp. e927-e935, (2008)
[6]  
Ferreiros N., Dresen S., Hermanns-Clausen M., Auwaerter V., Thierauf A., Muller C., Et al., Fatal and severe codeine intoxication in 3-year-old twins - Interpretation of drug and metabolite concentrations, Int J Legal Med, 123, 5, pp. 387-394, (2009)
[7]  
Madadi P., Hildebrandt D., Gong I.Y., Schwarz U.I., Ciszkowski C., Ross C.J., Et al., Fatal hydrocodone overdose in a child: Pharmacogenetics and drug interactions, Pediatrics, 126, 4, pp. e986-e989, (2010)
[8]  
Fortuna R.J., Robbins B.W., Caiola E., Joynt M., Halterman J.S., Prescribing of controlled medications to adolescents and young adults in the United States, Pediatrics, 126, 6, pp. 1108-1116, (2010)
[9]  
Landen M.G., Castle S., Nolte K.B., Gonzales M., Escobedo L.G., Chatterjee B.F., Et al., Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in new Mexico, Am J Epidemiol, 157, 3, pp. 273-278, (2003)
[10]  
De Wildt S.N., Tibboel D., Leeder J.S., Drug metabolism for the paediatrician, Arch Dis Child, 99, 12, pp. 1137-1142, (2014)